We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 28, 2021

Empagliflozin and Myocardial Flow Reserve

Journal of the American Heart Association


Additional Info

Journal of the American Heart Association
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
J Am Heart Assoc 2021 Jul 19;[EPub Ahead of Print], M Jürgens, M Schou, P Hasbak, A Kjær, E Wolsk, B Zerahn, M Wiberg, NH Brandt-Jacobsen, P Gæde, P Rossing, J Faber, SE Inzucchi, F Gustafsson, C Kistorp

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading